Alzheimer’s News From Florida - 7/30/08
Elan shares fall over Alzheimer’s drug results
The Miami Herald (The Associated Press)
Due to disappointing trial results of the Alzheimer’s drug bapineuzumab, shares of the Irish biotech firm Elan fell. It is developing the drug with the American firm Wyeth.
Alzheimer’s drug shows promise
South Florida Sun-Sentinel
A new Alzheimer’s drug developed by TauRx Therapeutics in Singapore is showing promising results in its trials.
